93898-91-0

Basic information

• Product Name: CHEMBRDG-BB 7955036
• Synonyms: CHEMBRDG-BB 7955036;2-(2-Phenylethoxy)benzaldehyde;Albb-004761;2-(2-phenylethoxy)benzaldehyde(SALTDATA: FREE)
• CAS NO: 93898-91-0
• Molecular Formula: C₁₅H₁₄O₂
• Molecular Weight: 226.28
• Mol File: 93898-91-0.mol
• Article Data: 4

Chemical Properties

• Melting Point: 71-73.5 °C(Solv: ethanol (64-17-5))
• Boiling Point: 387.8°C at 760 mmHg
• Flash Point: 178.4°C
• Appearance: /
• Density: 1.118g/cm³
• Vapor Pressure: 3.2E-06mmHg at 25°C
• Refractive Index: 1.595
• CAS DataBase Reference: CHEMBRDG-BB 7955036(CAS DataBase Reference)
• NIST Chemistry Reference: CHEMBRDG-BB 7955036(93898-91-0)
• EPA Substance Registry System: CHEMBRDG-BB 7955036(93898-91-0)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 93898-91-0(Hazardous Substances Data)

Usage

General Description

CHEMBRDG-BB 7955036 is a chemical compound with the molecular formula C23H26N4O2S. It is classified as a benzamide derivative and is believed to exhibit biological activity. The chemical structure of CHEMBRDG-BB 7955036 contains a benzene ring, an amide group, and a thiazole ring, which suggests potential pharmaceutical applications. However, further research is needed to fully understand the properties and potential uses of this compound.

InChI:InChI=1/C15H14O2/c16-12-14-8-4-5-9-15(14)17-11-10-13-6-2-1-3-7-13/h1-9,12H,10-11H2

Upstream product

• 90-02-8 salicylaldehyde 
• 103-63-9 1-phenyl-2-bromoethane 

Downstream Products

• 330824-24-3 (2-phenethyloxy-phenyl)-methanol 
• 1026879-20-8 2-(2-phenethyloxy-phenyl)-N,N-dipropyl-acetamide 
• 916908-17-3 (2-phenethyloxy-phenyl)-acetic acid 
• 1036483-53-0 1-Chloromethyl-2-phenethyloxy-benzene 
• 1459215-91-8 (L,Z)-2-(-5-(2-phenethyloxybenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)-3-phenylpropanoic acid 

Relevant articles and documents

Structural isomers of cinnamic hydroxamic acids block HCV replication via different mechanisms

A set of ortho-, meta- and para-substituted cinnamic hydroxamic acids (CHAs) was synthesized. In each series of structural isomers, a phenyl substituent was linked to an aromatic ring of the parent cinnamic acid via a linker of one to four atoms in length

IGF-1R INHIBITOR

The present invention provides a type I insulin-like growth factor receptor (IGF-1R) inhibitor comprising, as an active ingredient, an indazole derivative represented by Formula (I): {wherein R1 represents -NR4R5 [wherein R4 represents a hydrogen atom or the like, R5 represents substituted or unsubstituted lower alkyl, -C(=O)R6 (wherein R6 represents substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl or the like), or the like], or the like, and R2 and R3 may be the same or different and each represents a hydrogen atom, hydroxy, substituted or unsubstituted lower alkoxy, or the like} or a pharmaceutically acceptable salt thereof, and the like.